Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies

被引:395
作者
Hemmann, Stefanie
Graf, Juergen
Roderfeld, Martin
Roeb, Elke
机构
[1] Univ Hosp Giessen & Marburg GmbH, Dept Med 2, D-35392 Giessen, Germany
[2] Univ Hosp Giessen & Marburg GmbH, Dept Anaesthesiol & Intens Care, D-35033 Marburg, Germany
关键词
liver; fibrosis; MMP; TIMP; matrix; metalloproteinase; tissue; inhibitor; therapy; expression;
D O I
10.1016/j.jhep.2007.02.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In liver tissue matrix metalloproteinases (MMPs) and their specific inhibitors (tissue inhibitors of metalloproteinases, TIMPs) play a pivotal role in both, fibrogenesis and fibrolysis. The current knowledge of the pathophysiology of liver fibrogenesis with special emphasis on MMPs and TIMPs is presented. A systematic literature search was conducted. All experimental models of liver fibrosis that evaluated a defined anti-fibrotic intervention in vivo or in vitro considering MMPs and TIMPs were selected. The methodological quality of all these publications has been critically appraised using an objective scoring system and the content has been summarized in a table. (C) 2007 European Association for the Study of the Liver. Published by Elsevier BN. All rights reserved.
引用
收藏
页码:955 / 975
页数:21
相关论文
共 186 条
  • [81] TGF-β1 modulates matrix metalloproteinase-13 expression in hepatic stellate cells by complex mechanisms involving p38MAPK, PI3-kinase, AKT, and p70S6k
    Lechuga, CG
    Hernández-Nazara, ZH
    Rosales, JAD
    Morris, ER
    Rincón, AR
    Rivas-Estilla, AM
    Esteban-Gamboa, A
    Rojkind, M
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2004, 287 (05): : G974 - G987
  • [82] Differential role of p38 in IL-1α induction of MMP-9 and MMP-13 in an established liver myofibroblast cell line
    Lee, HS
    Miau, LH
    Chen, CH
    Chiou, LL
    Huang, GT
    Yang, PM
    Sheu, JC
    [J]. JOURNAL OF BIOMEDICAL SCIENCE, 2003, 10 (06) : 757 - 765
  • [83] Lee SH, 2003, PLANTA MED, V69, P990, DOI 10.1055/s-2003-45143
  • [84] Tetrandrine prevents tissue inhibitor of metalloproteinase-1 messenger RNA expression in rat liver fibrosis
    Lee, SH
    Nan, JX
    Sohn, DH
    [J]. PHARMACOLOGY & TOXICOLOGY, 2001, 89 (04): : 214 - 216
  • [85] α-Metanocyte-stimulating hormone gene therapy reverses carbon tetrachloride induced liver fibrosis in mice
    Lee, Tsung-Hsing
    Jawan, Bruno
    Chou, Wen-Ying
    Lu, Cheng-Nan
    Wu, Chia-Ling
    Kuo, Hsiao-Mei
    Concejero, Allan M.
    Wang, Cheng-Haung
    [J]. JOURNAL OF GENE MEDICINE, 2006, 8 (06) : 764 - 772
  • [86] LI G, 2006, J GENE MED
  • [87] Li Xu, 2005, World J Gastroenterol, V11, P4807
  • [88] Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis
    Lichtinghagen, R
    Bahr, MJ
    Wehmeier, M
    Michels, D
    Haberkorn, CI
    Arndt, B
    Flemming, P
    Manns, MP
    Boeker, KHW
    [J]. CLINICAL SCIENCE, 2003, 105 (03) : 373 - 382
  • [89] Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C
    Lichtinghagen, R
    Michels, D
    Haberkorn, CI
    Arndt, B
    Bahr, M
    Flemming, P
    Manns, MP
    Boeker, KHW
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 (02) : 239 - 247
  • [90] Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes
    Lin, Y
    Xie, WF
    Chen, YX
    Zhang, X
    Zeng, X
    Qiang, H
    Chen, WZ
    Yang, XJ
    Han, ZG
    Zhang, ZB
    [J]. LIVER INTERNATIONAL, 2005, 25 (04) : 796 - 807